Command Palette
Search for a command to run...
Information
Disclaimer and funders
The goals of this website are to provide patients and carers with the tools to advocate on an individual or national level for clinical trial access and to help them have informed conversations with their healthcare providers about clinical trial options.
This website is not meant to make recommendations or assumptions of the user's eligibility for a clinical trial. This website is intended to be used as a guide and reference to build the user's knowledge of available clinical trials. Please always consult your clinician for further information before considering clinical trial enrolment. Feel free to ask your healthcare team any questions you might have about treatment options, clinical trials, etc.
We are thankful to the following companies which financially supported this initiative (in alphabetical order):
Alexion AstraZeneca
Beigene
GlaxoSmithKline (GSK)
Janssen
Kite, a Gilead Company
Prothena Biosciences
Regeneron
Roche
Sandoz
Sanofi
The supporters of this website do not have control over the content of the website and cannot be held accountable for the information provided.
We are thankful for the pharmaceutical companies, our members and myeloma/AL amyloidosis doctors for their contributions and advice in creating and maintaining this platform with the most up-to-date information.
Our main source of information is clinicaltrials.gov and we also rely on updates from sponsors, hospitals and from our members across Europe. Depending on these updates, the Navigator may not be always up-to-date, despite our best efforts. Moreover, trials for which sponsors have not communicated site information cannot be included in this tool. If you notice mistakes or would like to provide us with further information, please use the contact us or feedback page.